Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
623-632
Author(s):
Carmen M. Klass and Dong M. Shin
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
650-665
Author(s):
Igor Astsaturov, Roger B. Cohen and Paul Harari
Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
666-673
Author(s):
Syed M. Ahmed and Ezra E.W. Cohen
Recent Approaches in Chemoprevention of Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
681-688
Author(s):
Charles Y.F. Young
Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Journal:
Current Neurovascular Research
Volume:
4
Page:
289-294
Author(s):
Karni S. Moshal, Clacy K. Camel, Ganesh K. Kartha, Mesia M. Steed, Neetu Tyagi, Utpal Sen, Y. James Kang, David Lominadze, Claudio Maldonado and Suresh C. Tyagi
“SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Journal:
Current Neurovascular Research
Volume:
4
Page:
295-302
Author(s):
Kenneth Maiese, Zhao Zhong Chong and Yan Chen Shang
Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
236-241
Author(s):
Teresa Troiani, Tina Cascone, John Heymach and Fortunato Ciardiello
Optimizing Anti-EGFR Strategies in Cancer Treatment
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
267-275
Author(s):
Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo
Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
276-283
Author(s):
Floriana Morgillo, Giampaolo Tortora and Fortunato Ciardiello
Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
284-291
Author(s):
Maria Pia Morelli, Jennifer Spratlin and S. Gail Eckhardt